Related references
Note: Only part of the references are listed.Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer
Shunchao Yan et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Estrogen Receptor-α Quantification in Breast Cancer: Concordance Between Immunohistochemical Assays and mRNA-In Situ Hybridization for ESR1 Gene
Christian Thomsen et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2020)
Insights into the Role of Estrogen Receptor beta in Triple-Negative Breast Cancer
Assunta Sellitto et al.
CANCERS (2020)
The role of estrogen receptor beta in breast cancer
Yujing Zhou et al.
BIOMARKER RESEARCH (2020)
ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasis
Jordan M. Reese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Estrogen receptor-beta is a potential target for triple negative breast cancer treatment
David Austin et al.
Oncotarget (2018)
High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort
Karin Elebro et al.
CLINICAL CANCER RESEARCH (2017)
Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity
Adam W. Nelson et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Expression of ERβ gene in breast carcinoma and the relevance in neoadjuvant therapy
Jing Chang et al.
ONCOLOGY LETTERS (2017)
ERα and ERβ co-expression: An indicator of aggressive tumors and hormonal sensitivity
Mohamed Oueslati et al.
ONCOLOGY LETTERS (2017)
Insufficient antibody validation challenges oestrogen receptor beta research
Sandra Andersson et al.
NATURE COMMUNICATIONS (2017)
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories
Emina E. Torlakovic et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2017)
ERβ overexpression results in endocrine therapy resistance and poor prognosis in postmenopausal ERα-positive breast cancer patients
Liying Guo et al.
ONCOLOGY LETTERS (2016)
Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis
Weige Tan et al.
ONCOTARGET (2016)
Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)-first results from PathIESaEuro
V. Speirs et al.
ANNALS OF ONCOLOGY (2015)
ERβ1 inversely correlates with PTEN/PI3K/AKT pathway and predicts a favorable prognosis in triple-negative breast cancer
Jin Wang et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Estrogen receptors β1 and β2 are associated with distinct responses of estrogen receptor α-positive breast carcinoma to adjuvant endocrine therapy
Eugen Dhimolea et al.
CANCER LETTERS (2015)
Expression and prognostic value of estrogen receptor β in patients with triple-negative and triple-positive breast cancer
Liying Guo et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
The potential role of estrogen receptor β2 in breast cancer
Jong-Min Baek et al.
INTERNATIONAL JOURNAL OF SURGERY (2015)
Biologic Roles of Estrogen Receptor-β and Insulin-Like Growth Factor-2 in Triple-Negative Breast Cancer
Nalo Hamilton et al.
BIOMED RESEARCH INTERNATIONAL (2015)
ERβ splice variant expression in four large cohorts of human breast cancer patient tumors
Hallie Wimberly et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Estrogen receptor beta in breast cancer
Lars-Arne Haldosen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients
Liying Guo et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
A bi-faceted role of estrogen receptor β in breast cancer
Etienne Leygue et al.
ENDOCRINE-RELATED CANCER (2013)
Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma
Miki I. Chantzi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Different associations of estrogen receptor β isoforms, ERβ1 and ERβ2, expression levels with tumor size and survival in early- and late-onset breast cancer
Vesna Mandusic et al.
CANCER LETTERS (2012)
Evaluation of ER-α, ER-β1 and ER-β2 expression and correlation with clinicopathologic factors in invasive luminal subtype breast cancers
Huiming Zhang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2012)
Prognostic Significance of High Expression of ER-beta in Surgically Treated ER-Positive Breast Cancer Following Endocrine Therapy
Tae-Jung Kim et al.
JOURNAL OF BREAST CANCER (2012)
Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibody
Xianglin Wu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues
Kemal Kursat Bozkurt et al.
PATHOLOGY RESEARCH AND PRACTICE (2012)
Identification of Estrogen Receptor Dimer Selective Ligands Reveals Growth-Inhibitory Effects on Cells That Co-Express ERα and ERβ
Emily Powell et al.
PLOS ONE (2012)
The Role of Estrogen Receptor-β in Breast Cancer
Leigh C. Murphy et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2012)
Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers
Max Yan et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Measurement of ER and PR status in breast cancer using the QuantiGene2.0 assay
Byung Joo Chae et al.
PATHOLOGY (2011)
Estrogen receptor β2 and β5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion
Yuet-Kin Leung et al.
ENDOCRINE-RELATED CANCER (2010)
Estrogen receptor-β expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
Jonathan D. Marotti et al.
MODERN PATHOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Evaluation of ERα, PR and ERβ isoforms in neoadjuvant treated breast cancer
Martin Wurster et al.
ONCOLOGY REPORTS (2010)
Estrogen Receptor-beta mRNA Is Associated with Adverse Outcome in Patients with Breast Cancer
G. C. Markey et al.
TUMOR BIOLOGY (2009)
Nuclear and cytoplasmic expression of ERβ1, ERβ2, and ERβ5 identifies distinct prognostic outcome for breast cancer patients
Abeer M. Shaaban et al.
CLINICAL CANCER RESEARCH (2008)
Clinical importance of estrogen receptor-β evaluation in breast cancer patients treated with adjuvant tamoxifen therapy
Naoko Honma et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Estrogen receptor alpha negative breast cancer patients: Estrogen receptor beta as a therapeutic target
George P. Skliris et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
ER beta in breast cancer - Onlooker, passive player, or active protector?
Emily M. Fox et al.
STEROIDS (2008)
Oestrogen receptors α and β show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer
S. Borgquist et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study
Flavia Novelli et al.
BREAST CANCER RESEARCH (2008)
Expression of estrogen receptor β wild-type and its variant ERβcx/β2 is correlated with better prognosis in breast cancer
Hiroshi Sugiura et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2007)
Association of oestrogen receptor beta 2 (ERβ2/ERβcx) with outcome of adjuvant endocrine treatment for primary breast cancer -: a retrospective study
Raman Vinayagam et al.
BMC CANCER (2007)
Estrogen receptor β2 negatively regulates the transactivation of estrogen receptor α in human breast cancer cells
Chunyan Zhao et al.
CANCER RESEARCH (2007)
Estrogen receptor alpha (ERα) mRNA copy numbers in immunohistochemically ERα-positive-, and negative breast cancer tissues
Indira Poola et al.
BMC CANCER (2007)
Estrogen receptor beta expression is associated with tamoxifen response in ER alpha-negative breast carcinoma
Sofia K. Gruvberger-Saal et al.
CLINICAL CANCER RESEARCH (2007)
Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumours
G. P. Skliris et al.
BRITISH JOURNAL OF CANCER (2006)
Estrogen receptor (ER)-β isoforms:: A key to understanding ER-β signaling
Yuet-Kin Leung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Estrogen receptor α-negative breast cancer tissues express significant levels of estrogen-independent transcription factors, ERβ1 and ERβ5:: Potential molecular targets for chernoprevention
I Poola et al.
CLINICAL CANCER RESEARCH (2005)
A multi-centre investigation towards reaching a consensus on the immunohistochemical detection of ERβ in archival formalin-fixed paraffin embedded human breast tissue
PJ Carder et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Estrogen receptors beta4 and Beta5 are full length functionally distinct ERβ isoforms -: Cloning from human ovary and functional characterization
I Poola et al.
ENDOCRINE (2005)
Increased estrogen receptor βcx expression during mammary carcinogenesis
M Esslimani-Sahla et al.
CLINICAL CANCER RESEARCH (2005)
Estrogen receptor β in breast cancer:: Associations between ERβ, hormonal receptors, and other prognostic biomarkers
Y Choi et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2005)
Tamoxifen-resistant breast cancers show less frequent methylation of the estrogen receptor β but not the estrogen receptor αgene
HG Chang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
The expression of ERβcx in human breast cancer and the relationship to endocrine therapy and survival
C Palmieri et al.
CLINICAL CANCER RESEARCH (2004)
Relevance of breast cancer cell lines as models for breast tumours: an update
M Lacroix et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
ERβ exerts multiple stimulative effects on human breast carcinoma cells
YF Hou et al.
ONCOGENE (2004)
Correlation of mRNA for oestrogen receptor beta splice variants ERβ1, ERβ2/ERβcx and ERβ5 with outcome in endocrine-treated breast cancer
MPA Davies et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2004)
Wild-type oestrogen receptor beta (ERb1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers
PA O'Neill et al.
BRITISH JOURNAL OF CANCER (2004)
Inverse relationship between ER-β and SRC-1 predicts outcome in endocrine-resistant breast cancer
E Myers et al.
BRITISH JOURNAL OF CANCER (2004)
The favourable prognostic value of oestrogen receptor β immunohistochemical expression in breast cancer
L Nakopoulou et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells
DA Tonetti et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
Clinical significance of the expression of estrogen receptors α and β for endocrine therapy of breast cancer
H Iwase et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2003)
Declining estrogen receptor-beta expression defines malignant progression of human breast neoplasia
AM Shaaban et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Relationship of coregulator and oestrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer
LC Murphy et al.
BRITISH JOURNAL OF CANCER (2002)
Estrogen receptor beta splice variant rnRNAs are differentially altered during breast carcinogenesis
I Poola et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2002)
Evaluation of seven oestrogen receptor β antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue
GP Skliris et al.
JOURNAL OF PATHOLOGY (2002)
Evaluation of oestrogen receptor β wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers
Y Omoto et al.
EUROPEAN JOURNAL OF CANCER (2002)
Estrogen receptors and proliferation markers in primary and recurrent breast cancer
EV Jensen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular and pharmacological aspects of antiestrogen resistance
R Clarke et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2001)
Share Paper
